A simultaneous presentation of drug-induced lupus with drug-induced ANCA vasculitis secondary to hydralazine use in a patient with sarcoidosis

Maria Catalina Espinosa; Belicia Ding; Kati Choi; Daniel N Cohen; Marco Marcelli; Onome Whiteru Ifoeze

doi:10.1080/08998280.2019.1570422

A simultaneous presentation of drug-induced lupus with drug-induced ANCA vasculitis secondary to hydralazine use in a patient with sarcoidosis

Proc (Bayl Univ Med Cent). 2019 Mar 27;32(2):231-234. doi: 10.1080/08998280.2019.1570422. eCollection 2019 Apr.

Authors

Maria Catalina Espinosa¹, Belicia Ding¹, Kati Choi², Daniel N Cohen³, Marco Marcelli², Onome Whiteru Ifoeze²

Affiliations

¹ School of Medicine, Baylor College of MedicineHoustonTexas.
² Department of Medicine, Baylor College of MedicineHoustonTexas.
³ Department of Pathology and Immunology, Baylor College of MedicineHoustonTexas.

Abstract

Frequently used in the management of hypertension and heart failure, hydralazine is associated with the development of adverse rheumatologic side effects. The authors highlight a unique case of drug-induced lupus and drug-induced anti-neutrophil cytoplasmic antibody (ANCA) vasculitis from hydralazine use in a 50-year-old man with sarcoidosis and hypertension.

Keywords: Drug-induced anti-neutrophil cytoplasmic antibody vasculitis; drug-induced lupus; hydralazine; leukocytoclastic vasculitis.

Publication types

Case Reports